Related Experiment Video
Updated: Feb 11, 2026

Author Spotlight: Generation of and Comparison Between Patient-Derived Gastric Organoids from Different Regions of the Stomach
Published on: January 26, 2024
Human gastric cancer modelling using organoids
Therese Seidlitz1, Sebastian R Merker1, Alexander Rothe1
1Department of Visceral, Thoracic and Vascular Surgery, University Hospital Carl Gustav Carus, Medical Faculty, Technische Universität Dresden, Dresden, Germany.
Objective:
Gastric cancer is the second leading cause of cancer-related deaths and the fifth most common malignancy worldwide. In this study, human and mouse gastric cancer organoids were generated to model the disease and perform drug testing to delineate treatment strategies.
Design:
Human gastric cancer organoid cultures were established, samples classified according to their molecular profile and their response to conventional chemotherapeutics tested. Targeted treatment was performed according to specific druggable mutations. Mouse gastric cancer organoid cultures were generated carrying molecular subtype-specific alterations.
Results:
Twenty human gastric cancer organoid cultures were established and four selected for a comprehensive in-depth analysis. Organoids demonstrated divergent growth characteristics and morphologies. Immunohistochemistry showed similar characteristics to the corresponding primary tissue. A divergent response to 5-fluoruracil, oxaliplatin, irinotecan, epirubicin and docetaxel treatment was observed. Whole genome sequencing revealed a mutational spectrum that corresponded to the previously identified microsatellite instable, genomic stable and chromosomal instable subtypes of gastric cancer. The mutational landscape allowed targeted therapy with trastuzumab for ERBB2 alterations and palbociclib for CDKN2A loss. Mouse cancer organoids carrying Kras and Tp53 or Apc and Cdh1 mutations were characterised and serve as model system to study the signalling of induced pathways.
Conclusion:
We generated human and mouse gastric cancer organoids modelling typical characteristics and altered pathways of human gastric cancer. Successful interference with activated pathways demonstrates their potential usefulness as living biomarkers for therapy response testing.
Insights
Gastric cancer organoids were developed to model human disease and test drug responses. These models accurately reflect patient tumors and can predict treatment effectiveness, guiding personalized gastric cancer therapy.
Area of Science:
- Oncology
- Gastroenterology
- Translational Medicine
Background:
- Gastric cancer is a leading cause of cancer mortality globally.
- Effective treatment strategies are needed to improve patient outcomes.
Purpose of the Study:
- To develop and characterize human and mouse gastric cancer organoids.
- To utilize these organoids for drug testing and personalized therapy prediction.
Main Methods:
- Established and analyzed human gastric cancer organoid cultures.
- Classified organoids by molecular profile and tested responses to chemotherapeutics.
- Generated mouse gastric cancer organoids with specific mutations.
Main Results:
- Organoids mirrored primary tumor characteristics and molecular subtypes (microsatellite instable, genomic stable, chromosomal instable).
- Observed divergent responses to conventional chemotherapies.
- Demonstrated successful targeted therapy for specific mutations (e.g., trastuzumab for ERBB2, palbociclib for CDKN2A loss).
Conclusions:
- Human and mouse gastric cancer organoids effectively model the disease.
- Organoids serve as valuable living biomarkers for predicting therapy response.
More Related Videos
Related Concept Videos
Gastric Motility
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
Gastric Emptying
Gastric Phase of Digestion
When food enters the stomach, it stretches the stomach walls and activates stretch receptors. This triggers local reflexes of the enteric nervous system, mediated through the myenteric plexus. These...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Cancer
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...

